Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Select Advanced Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03053466
What this trial is testing

APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

Who this might be right for
Solid TumorMicrosatellite InstabilityMismatch Repair Deficiency+1 more
Apollomics (Australia) Pty. Ltd. 30
Not applicableUnknownNCT06080620
What this trial is testing

The Choice of Treatment Methods and Efficacy of LABC

Who this might be right for
Locally Advanced Breast Cancer
Peking Union Medical College Hospital 50
Testing effectiveness (Phase 2)Study completedNCT03035591
What this trial is testing

ODM-207 in Patients With Advance Solid Tumours

Who this might be right for
Solid Tumors
Orion Corporation, Orion Pharma 36
Large-scale testing (Phase 3)Study completedNCT00975897
What this trial is testing

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council 3,240
Not applicableStudy completedNCT05250817
What this trial is testing

Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bristol-Myers Squibb 501
Testing effectiveness (Phase 2)Looking for participantsNCT06193525
What this trial is testing

FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test

Who this might be right for
Advanced Breast Cancer
Erasmus Medical Center 66
Early research (Phase 1)Ended earlyNCT00585845
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

Who this might be right for
Malignant Epithelial MesotheliomaAdenocarcinoma of the PancreasCarcinoma, Non-Small-Cell Lung+1 more
Anza Therapeutics, Inc. 17
Large-scale testing (Phase 3)Study completedNCT04209855
What this trial is testing

Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
AbbVie 453
Testing effectiveness (Phase 2)Looking for participantsNCT06725758
What this trial is testing

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

Who this might be right for
Solid Tumours
Orion Corporation, Orion Pharma 315
Early research (Phase 1)Study completedNCT02503774
What this trial is testing

MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors.

Who this might be right for
Solid Tumors
MedImmune LLC 192
Testing effectiveness (Phase 2)Looking for participantsNCT06102824
What this trial is testing

Organoid-based Functional Precision Therapy for Advanced Breast Cancer

Who this might be right for
HER2-negative Breast CancerAdvanced Breast Cancer
Guangdong Provincial People's Hospital 252
Not applicableLooking for participantsNCT07343024
What this trial is testing

Methods of Identifying Effective Off-Guideline Treatments for Advanced Cancer Patients (CC N-of-1)

Who this might be right for
Advanced Cancer
Cancer Commons 300
Testing effectiveness (Phase 2)Study completedNCT04339062
What this trial is testing

Cemiplimab in AlloSCT/SOT Recipients With CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaAdvanced Cancer
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)UnknownNCT04974957
What this trial is testing

Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

Who this might be right for
Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 71
Testing effectiveness (Phase 2)Looking for participantsNCT07115043
What this trial is testing

Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more
AstraZeneca 120
Early research (Phase 1)Looking for participantsNCT05759923
What this trial is testing

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

Who this might be right for
Advanced Ovarian CarcinomaAdvanced Renal Cell CarcinomaAdvanced Pancreatic Carcinoma+5 more
Molecure S.A. 40
Testing effectiveness (Phase 2)Ended earlyNCT01038037
What this trial is testing

First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Vejle Hospital 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT07718737
What this trial is testing

Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Multitude Therapeutics Inc. 512
Early research (Phase 1)Active Not RecruitingNCT03220477
What this trial is testing

Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT03679767
What this trial is testing

INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Who this might be right for
Metastatic Non-small Cell Lung CancerLocally Advanced Urothelial CancerMetastatic Urothelial Cancer+4 more
Incyte Corporation 121
Next Page